OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Clinical Pharmacology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence	165
Blinding and expectancy confounds in psychedelic randomized controlled trials	146
Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion	65
Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications	46
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis	45
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause	42
Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets	37
Clinical pharmacology and PK/PD translation of the second-generation Bruton’s tyrosine kinase inhibitor, zanubrutinib	36
An update on the complex relationship between clozapine and pneumonia	34
Activation of Nrf2 signaling pathway by natural and synthetic chalcones: a therapeutic road map for oxidative stress	34
Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome	34
Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors	34
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations	33
Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis	30
Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis	29
Prediction of vancomycin dose on high-dimensional data using machine learning techniques	29
Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art	27
The Role of testosterone treatment in patients with metabolic disorders	26
Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria	26
Prevention of colistin induced nephrotoxicity: a review of preclinical and clinical data	24
Novel therapies for AML: a round-up for clinicians	24
Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase	23
An update on drug development for the treatment of nonalcoholic fatty liver disease – from ongoing clinical trials to future therapy	23
UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions	23